Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPLZL.L Regulatory News (PLZL)

  • There is currently no data for PLZL

Rule 8.1- OJSC Polyus Gold

3 Jul 2009 10:10

RNS Number : 0812V
Renaissance Capital Limited
03 July 2009
Ā 



Ā  FORM 8.1

DEALINGS BY OFFERORS, OFFEREE COMPANIES OR THEIR ASSOCIATES

FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS

(RulesĀ 8.1(a) and (b)(i)Ā ofĀ theĀ TakeoverĀ Code)

1. KEY INFORMATION

Name of person dealingĀ (Note 1)

Subsidiaries of Renaissance Capital Holdings Limited trading under theĀ Renaissance CapitalĀ brand

Company dealt in

OJSC Polyus Gold

Class of relevant security to which the dealings being disclosed relateĀ (NoteĀ 2)

1 RUB ordinary (OJSC Polyus Gold)

Date of dealing

2Ā JulyĀ 2009

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

(a) InterestsĀ and short positionsĀ (following dealing) in the class of relevant security dealt inĀ (Note 3)

Long

Short

Number (%)

Number (%)

(1) Relevant securitiesĀ 

240,308.5 (0.12%)

224,406 (0.12%)

(2) Derivatives (other than options)

1,240,000 (0.65%)

(3) Options and agreements to purchase/sell

Total

240,308.5 (0.12%)

1,494,406 (0.78%)

(b) InterestsĀ and short positionsĀ in relevant securities of the company, other than theĀ classĀ dealt inĀ (Note 3)

Class of relevant security:

Long

Short

Number (%)

Number (%)

(1) Relevant securitiesĀ 

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

(c) Rights to subscribeĀ (Note 3)

Class of relevant security:

Details

3. DEALINGSĀ (Note 4)

(a) Purchases and sales

Total number of securities purchased

Highest price paidĀ (Note 3)

Lowest price paidĀ (Note 3)

3,740Ā rdinary shares

24,413Ā ordinary shares

3,593Ā ADRs (conversion ratio 1 ADR:0.5 share)

USDĀ 38.406

RURĀ 1199.494

USDĀ 19.710

USDĀ 37.456

RURĀ 957.592

USDĀ 19.601

Total number of securities sold

Highest price receivedĀ (Note 3)

Lowest price receivedĀ (Note 3)

4,413Ā ordinary shares

27,306Ā ordinary shares

USDĀ 38.457

RURĀ 1203.090

USDĀ 37.656

RURĀ 957.592

(b) Derivatives transactions (other than options)

Product name,Ā 

e.g. CFD

Long/shortĀ (Note 6)

Number of securitiesĀ (Note 7)

Price per unitĀ (Note 5)

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Product name,

e.g.Ā callĀ option

Writing, selling, purchasing, varying etc.

Number of securitiesĀ to which the option relatesĀ (Note 7)

Exercise

priceĀ 

Type,Ā e.g. American, European etc.

ExpiryĀ 

date

Option money

paid/receivedĀ per unitĀ (Note 5)

(ii) Exercising

Product name,Ā e.g.Ā call option

Number of securitiesĀ 

Exercise priceĀ per unitĀ (Note 5)

(d) Other dealings (including new securities)Ā (Note 4)

Nature of transactionĀ (Note 8)

Details

PriceĀ per unitĀ (if applicable)Ā (Note 5)Ā 

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relatingĀ toĀ the voting rights of any relevant securities under any option referred to on this form orĀ relating to the voting rights orĀ future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached?Ā (Note 9) YES

Date of disclosure

3Ā JulyĀ 2009

Contact name

Bridget Andrews

Telephone number

020 7367 7988

Name of offeree/offerorĀ with whichĀ associated

Jenington International Inc (an indirect wholly owned subsidiary of OJSC Polyus Gold)Ā 

Specify category and nature of associate statusĀ (Note 10)

Acting in concertĀ as a result of a 50%Ā less one-half of one shareĀ ownership of Renaissance Financial Holdings Limited by ONEXIM Group.

Notes

TheĀ NotesĀ onĀ Form 8.1 can be viewed on the Takeover Panel's website atĀ www.thetakeoverpanel.org.uk

SUPPLEMENTAL FORM 8

DETAILS OF OPENĀ POSITIONSĀ 

(This form should be attached to Form 8.1, Form 8.1(b)(ii)Ā or Form 8.3, as appropriate)

OPENĀ POSITIONSĀ (NoteĀ 1)

Product name,

e.g.Ā call option

Written or purchased

Number of securitiesĀ to which the option or derivative relates

Exercise priceĀ (Note 2)

Type, e.g. American, European etc.

Expiry date

Ā Total return swap

Written

1,750,000 ADRs

Market price at termination date

Traders agreed on securities settlement - confirmation stated cash settled

24 November 2009

Total return swap

Written

730,000 ADRs

Market price at termination date

Traders agreed on securities settlement - confirmation stated cash settled

17 July 2009

Notes

1.Ā Where there are open option positions or open derivative positions (except for CFDs), full details should be given.Ā Ā Full details of anyĀ Ā existing agreements to purchase or to sellĀ Ā shouldĀ also be given on this form.Ā Ā 

2. For all prices and other monetary amounts, the currency must be stated.

For details of the Code's dealing disclosure requirements, see Rule 8 and its Notes which can be viewed on the Takeover Panel's website atĀ www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
Ā 
END
Ā 
Ā 
DCCKXLBBKDBBBBQ
Date   Source Headline
11th May 202312:00 pmRNSFY2022 dividend recommendation
28th Apr 20234:15 pmRNSAnnual Review
28th Apr 202312:02 pmRNSNotice of 2022 AGM
20th Mar 202311:15 amRNSNotice of change of the DR programs depositary
17th Mar 20233:01 pmRNSUpdate on payments on 2023 and 2024 Eurobonds
17th Mar 20233:00 pmRNSUpdate on payments on 2023 and 2024 Eurobonds
15th Mar 20232:01 pmRNSFinancial results for 2H2022 and FY2022
14th Mar 20232:23 pmRNSNotice of financial results for 2H2022 and FY2022
21st Feb 20237:00 amRNSOperating results for 2H 2022 and full year 2022
16th Feb 20231:37 pmRNSPolyus priced 20 billion rouble bonds issue
14th Feb 20231:02 pmRNSRepayment of Eurobonds due 2023
14th Feb 20231:00 pmRNSRepayment of Eurobonds due 2023
3rd Feb 20233:32 pmRNSUpdate on Level I DR program
2nd Feb 20233:15 pmRNSUpdate on Depositary for DR programs
30th Nov 20223:33 pmRNSUpdate on coupon payments in respect of 2028 Notes
30th Nov 20223:30 pmRNSUpdate on coupon payments in respect of 2028 Notes
28th Nov 20223:30 pmRNSChanges in top management
30th Sep 20223:51 pmRNSAGM results
22nd Sep 20224:58 pmRNSUpdate on coupon payments in respect of 2023 Notes
22nd Sep 20224:43 pmRNSUpdate on coupon payments in respect of 2023 Notes
21st Sep 20227:05 amRNSOperating results for the first half of 2022
21st Sep 20227:00 amRNSFinancial results for the first half of 2022
13th Sep 20224:47 pmRNSUpdate on coupon payments in respect of 2024 Notes
13th Sep 20224:45 pmRNSUpdate on coupon payments in respect of 2024 Notes
9th Sep 20229:03 amRNSConsent Solicitation Results
9th Sep 20229:00 amRNSConsent Solicitation Results
6th Sep 202210:01 amRNSNotice of 2H2021 Dividend Recommendation and AGM
30th Aug 20227:00 amRNSNotice of the first half of 2022 financial results
25th Aug 20224:05 pmRNSNoteholders’ consent solicitation extension
25th Aug 20224:00 pmRNSExtension of Consent Solicitation
24th Aug 202210:45 amRNSPJSC Polyus priced CNY 4.6 billion bonds issue
17th Aug 20221:12 pmRNSNotice to holders of depositary receipts
15th Aug 202212:54 pmRNSPJSC Polyus publishes its Climate Strategy
11th Aug 20223:03 pmRNSExtension of Consent Solicitation
11th Aug 20223:00 pmRNSExtension of Consent Solicitation
5th Aug 20221:35 pmRNSUpdate on Proposals for 2023 and 2024 Notes
5th Aug 20221:30 pmRNSUpdate on Proposals for 2023 and 2024 Notes
29th Jul 202212:03 pmRNSPJSC Polyus Completes The Buyback Programme
28th Jul 20225:44 pmRNSConsent Solicitation Results and Extension
28th Jul 20225:41 pmRNSConsent Solicitation Results and Extension
20th Jul 20228:06 amRNSNoteholders’ Consent Solicitation Launch
20th Jul 20228:00 amRNSConsent Solicitation Launch Announcement
19th Jul 20225:56 pmRNSEffectiveness of Proposals for 2023 and 2024 Notes
15th Jul 20224:44 pmRNSResults of Consent Solicitation
15th Jul 20224:35 pmRNSResults of the Consent Solicitation
1st Jul 20225:33 pmRNSNoteholders’ consent solicitation extension
1st Jul 20225:23 pmRNSExtension of Consent Solicitation
24th Jun 20223:47 pmRNSNoteholders’ consent solicitation launch
24th Jun 20223:26 pmRNSPolyus Finance Plc announces Consent Solicitation
17th Jun 20222:05 pmRNSAcquisition of the Chulbatkan deposit

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.